Moderna announces supply agreement with the Argentina government for 20 million doses of Moderna’s COVID-19 vaccine.
Moderna. announced a supply agreement in a July 12, 2021 press release with the government of Argentina for 20 million doses of Moderna’s COVID-19 vaccine or its updated variant booster vaccine candidate, if authorized. Delivery will begin the first quarter of 2022.
“We appreciate the support from the government of Argentina with this supply agreement for doses of the Moderna COVID-19 vaccine or our variant booster candidates,” said Stéphane Bancel, Chief Executive Officer of Moderna, in a press release. “We are committed to making our vaccine available around the world as we seek to address the pandemic with our COVID-19 vaccine.”
The Moderna COVID-19 vaccine is an mRNA vaccine against COVID-19 encoding for a prefusion stabilized form of the spike protein. Moderna has received emergency authorization for the vaccine for adults from health agencies in more than 50 countries and an Emergency Use Listing from WHO.
Source: Moderna
FDA Approves Pfizer Combination Regimen for Treating R/R Diffuse Large B-Cell Lymphoma
February 14th 2025The approval of an ADCETRIS combination regimen is based on positive data from a Phase III trial where the combination regimen demonstrated a clinically meaningful reduction in the risk of death.